Literature DB >> 27309630

Continuous infusion versus intermittent flushing: maintaining peripheral intravenous access in newborn infants.

D Stok1, J W Wieringa1.   

Abstract

OBJECTIVE: To compare the patency duration of a peripheral intravenous cannula (PIVC) using either continuous infusion with 5% dextrose or intermittent flushing with 0.9% saline. STUDY
DESIGN: Prospective comparative cohort study, including full-term newborn infants in whom PIVC were placed for the administration of antibiotics. In cohort 1 (n=48), 5% dextrose was infused at 3 ml h(-1); in cohort 2 (n=50), the cannula was flushed six times daily with 2 ml 0.9% saline. Primary outcome was the duration of PIVC patency. Secondary outcomes included the occurrence of complications, time required by the nursing staff and the cost of materials. RESULT: Duration of PIVC patency was similar. However, significantly, more complications occurred in cohort 1 (P=0.02), and both cost and time were significantly lower in cohort 2 (P=0.001).
CONCLUSION: Intermittent flushing and continuous infusion provide a similar duration of PIVC patency; however, intermittent flushing is associated with fewer complications, lower cost and reduced time.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27309630     DOI: 10.1038/jp.2016.94

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  12 in total

1.  A comparison of continuous infusion and intermittent flushing methods in peripheral intravenous catheters in neonates.

Authors:  A Kalyn; S Blatz; J Pinelli
Journal:  J Intraven Nurs       Date:  2000 May-Jun

2.  Predisposing factors for infiltration in children submitted to peripheral venous catheterization.

Authors:  Amanda Karina de Lima Jacinto; Ariane Ferreira Machado Avelar; Mavilde L G Pedreira
Journal:  J Infus Nurs       Date:  2011 Nov-Dec

3.  Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study.

Authors:  Inge J J Arnts; Johanna A Heijnen; Henriette T M Wilbers; Gert-Jan van der Wilt; Johannes M M Groenewoud; Kian D Liem
Journal:  J Adv Nurs       Date:  2011-07-03       Impact factor: 3.187

4.  Intermittent flushing improves cannula patency compared to continuous infusion for peripherally inserted venous catheters in newborns: results from a prospective observational study.

Authors:  Anna Perez; Isabelle Feuz; Barbara Brotschi; Vera Bernet
Journal:  J Perinat Med       Date:  2012-01-19       Impact factor: 1.901

5.  Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial.

Authors:  D G Maki; M Ringer
Journal:  Ann Intern Med       Date:  1991-05-15       Impact factor: 25.391

6.  Heparin for prolonging peripheral intravenous catheter use in neonates: a randomized controlled trial.

Authors:  A Upadhyay; K K Verma; P Lal; D Chawla; V Sreenivas
Journal:  J Perinatol       Date:  2014-12-04       Impact factor: 2.521

Review 7.  Heparin for prolonging peripheral intravenous catheter use in neonates.

Authors:  P S Shah; E Ng; A K Sinha
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

8.  Heparin lock intravenous line. Use in newborn infants. A controlled trial.

Authors:  J Taylor; R Shannon; H W Kilbride
Journal:  Clin Pediatr (Phila)       Date:  1989-05       Impact factor: 1.168

9.  The intravenous cannula for newborn infants requiring only intravenous medication: continuous infusion or intermittent flushing?

Authors:  Anndrea Flint; Mark Davies
Journal:  J Infus Nurs       Date:  2008 Nov-Dec

Review 10.  Assessment of the infant with a peripheral intravenous device.

Authors:  Janet Pettit
Journal:  Adv Neonatal Care       Date:  2003-10       Impact factor: 1.968

View more
  1 in total

1.  Respiratory mechanics evaluation of mice submitted to intravenous methacholine: Bolus vs. continuous infusion.

Authors:  Renato de L Vitorasso; Maria A de Oliveira; Wothan Tavares-de-Lima; Henrique T Moriya
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.